Transfusion-transmitted HBV infection with isolated anti-HBs-positive blood

被引:7
|
作者
Satake, Masahiro [1 ]
Yamagishi, Naoji [1 ]
Tanaka, Ami [1 ]
Goto, Naoko [2 ]
Sakamoto, Tomohiko [3 ]
Yanagino, Yusuke [3 ]
Furuta, Rika A. A. [1 ]
Matsubayashi, Keiji [1 ]
机构
[1] Japanese Red Cross, Cent Blood Inst, 2-1-67 Tatsumi,Koto Ku, Tokyo 1358521, Japan
[2] Japanese Red Cross, Blood Serv Headquarters, Tokyo, Japan
[3] Sakurabashi Watanabe Hosp, Dept Cardiovasc Surg, Osaka, Japan
关键词
anti-HBc; anti-HBs; NAT; OBI; vaccination; HEPATITIS-B-VIRUS; SURFACE-ANTIGEN; DONORS; ANTIBODIES;
D O I
10.1111/trf.17390
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BackgroundHepatitis B virus (HBV)-positive individuals with isolated anti-HBs are found among HBV vaccine recipients and healthy blood donors with no vaccination history. HBV infectivity from blood transfusions derived from such individuals remains unclear. Case PresentationA male patient who received transfusion with blood negative for individual donation-NAT, HBsAg and anti-HBc but weakly positive for anti-HBs developed typical transfusion-transmitted (TT)-HBV with anti-HBc response. The responsible blood donor was a frequent repeat donor showing a marked increase in anti-HBs titer without anti-HBc response 84 days after index donation. Test results for his past donations showed transient viremia with very low viral load and fluctuating low-level anti-HBs. The HBV vaccination history of this donor was unknown. DiscussionAnti-HBs and anti-HBc kinetics of the donor suggest a second antibody response to new HBV challenge, representing a vaccine breakthrough case. On the other hand, transient low-level viremia and fluctuating anti-HBs in the test results of past donations suggested chronic occult HBV infection with isolated anti-HBs. ConclusionWhatever the basic infection state, blood donors with isolated weak anti-HBs may include a small population with a risk of causing TT-HBV. Identifying individuals harboring such TT-HBV risk among individuals positive only for anti-HBs is difficult under current screening strategies. Active surveillance for the occurrence of TT-HBV with blood positive only for anti-HBs is necessary.
引用
收藏
页码:1250 / 1254
页数:5
相关论文
共 50 条
  • [21] Blood donor screening: how to decrease the risk of transfusion-transmitted hepatitis B virus?
    Niederhauser, Christoph
    Taleghani, Behrouz Mansouri
    Gmziani, Mauro
    Stolz, Martin
    Tinguely, Caroline
    Schneider, Philippe
    SWISS MEDICAL WEEKLY, 2008, 138 (9-10) : 134 - 141
  • [22] Demographic characteristics of transfusion-transmitted infections among blood donors in China
    Le Chang
    Junpeng Zhao
    Fei Guo
    Huimin Ji
    Lu Zhang
    Xinyi Jiang
    Lunan Wang
    BMC Infectious Diseases, 19
  • [23] Demographic characteristics of transfusion-transmitted infections among blood donors in China
    Chang, Le
    Zhao, Junpeng
    Guo, Fei
    Ji, Huimin
    Zhang, Lu
    Jiang, Xinyi
    Wang, Lunan
    BMC INFECTIOUS DISEASES, 2019, 19 (1)
  • [24] Anti-HBs-positive liver failure due to hepatitis B virus reactivation induced by rituximab
    Sera, Toshiki
    Hiasa, Yoichi
    Michitaka, Kojiro
    Konishi, Ichiro
    Matsuura, Kana
    Tokumoto, Yoshio
    Matsuura, Bunzo
    Kajiwara, Takeshi
    Masumoto, Toshikazu
    Horiike, Norio
    Onji, Morikazu
    INTERNAL MEDICINE, 2006, 45 (11) : 721 - 724
  • [25] The Risk of Transfusion-Transmitted Hepatitis E Virus: Evidence from Seroprevalence Screening of Blood Donations
    Wong, Li Ping
    Lee, Hai Yen
    Khor, Chee Sieng
    Abdul-Jamil, Juraina
    Alias, Haridah
    Abu-Amin, Noryati
    Mat-Radzi, Murniwati
    Rohimi, Nurul Ashila
    Mokhtardin, Hana Najian
    AbuBakar, Sazaly
    Zheng, Zizheng
    Wu, Ting
    Zhao, Qinjian
    Xia, Ningshao
    INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION, 2022, 38 (01) : 145 - 152
  • [26] Transfusion-Transmitted Hepatitis E: NAT Screening of Blood Donations and Infectious Dose
    Dreier, Jens
    Knabbe, Cornelius
    Vollmer, Tanja
    FRONTIERS IN MEDICINE, 2018, 5
  • [27] Modelling the risk of transfusion-transmitted syphilis: a reconsideration of blood donation testing strategies
    Jayawardena, Thisuri
    Hoad, Veronica
    Styles, Claire
    Seed, Clive
    Bentley, Peter
    Clifford, Vanessa
    Lacey, Sarina
    Gastrell, Tessa
    VOX SANGUINIS, 2019, 114 (02) : 107 - 116
  • [28] Seroprevalence of transfusion-transmitted infections among blood donors in Makkah, Saudi Arabia
    Minshawi, Faisal
    Abdulshakoor, Asim A.
    Alwakil, Emran M.
    Basfar, Ghaiyda
    Kabrah, Saeed
    Aslam, Akhmed
    Almasmoum, Hibah
    Mujalli, Abdulrahman
    Moaminah, Rabab H.
    Almoalad, Ghadeer A.
    Alwadani, Mohammed A.
    Alzahrani, Mohammad G.
    Alsehemi, Kholoud A.
    Refaat, Bassem
    JOURNAL OF INFECTION IN DEVELOPING COUNTRIES, 2024, 18 (06): : 957 - 963
  • [29] Seroprevalence changing trends of transfusion-transmitted infections amongst blood donors in a Regional Blood Transfusion Centre in north India
    Rawat, Akanksha
    Diwaker, Preeti
    Gogoi, Priyanka
    Singh, Bharat
    INDIAN JOURNAL OF MEDICAL RESEARCH, 2017, 146 : 642 - 645
  • [30] Nucleic acid amplification test: Bridging the gap in blood safety & re-evaluation of blood screening for cryptic transfusion-transmitted infection among Indian donors
    Datta, Sanghamitra
    Khillan, Kamini
    Ranjan, Vivek
    Wattal, Chand
    INDIAN JOURNAL OF MEDICAL RESEARCH, 2019, 149 (03) : 389 - 395